» Articles » PMID: 32405179

The Protective Effect of Zinc Against Liver Ischaemia Reperfusion Injury in a Rat Model of Global Ischaemia

Overview
Publisher Elsevier
Specialty Gastroenterology
Date 2020 May 15
PMID 32405179
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ischaemia-reperfusion injury (IRI) is a major obstacle during liver transplantation and resection surgeries for cancer, with a need for effective and safe drugs to reduce IRI. Zinc preconditioning has been shown to protect against liver IRI in a partial (70%) ischaemia model. However, its efficacy against a clinically relevant Pringle manoeuvre that results in global liver ischaemia (100%) is unknown.

Aims: The aim of this study was to test the efficacy of zinc preconditioning in a rat model of global liver ischaemia.

Methods: Rats were preconditioned via subcutaneous injection of 10 mg/kg of ZnCl, 24 h and 4 h before ischaemia. Total liver ischaemia (100%) was induced by placing a clamp across the portal triad for 30 min. Liver injury was assessed by serum alanine transaminase (ALT) and aspartate transaminase (AST) levels in blood taken before ischaemia (baseline) and at 1, 2, 4, 24, 48, 72, 96 and 120 hours after ischaemia. Animals were culled after 7 days, and the harvested livers were histologically analysed.

Results: On a two-way repeated-measures analysis of variance, there was a statistically significant (p = 0.025) difference in the mean ALT levels between saline- and ZnCl-treated groups. Specifically at 24 h after ischaemia, the ALT (341 ± 99 U/L) and AST (606 ± 78 U/L) in the zinc-treated group were significantly less than the ALT (2863 ± 828 U/L) and AST (3591 ± 948 U/L) values in the saline-treated group. Zinc significantly reduced neutrophil infiltration and necrosis compared with the saline control.

Conclusion: Zinc preconditioning reduces the overall hepatocellular damage from IRI. These results lay the foundation to assess the benefit of zinc preconditioning for clinical applications.

Citing Articles

The Roles and Pathogenesis Mechanisms of a Number of Micronutrients in the Prevention and/or Treatment of Chronic Hepatitis, COVID-19 and Type-2 Diabetes Mellitus.

Sumaily K Nutrients. 2022; 14(13).

PMID: 35807813 PMC: 9268086. DOI: 10.3390/nu14132632.


Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury.

Coni P, Pichiri G, Lachowicz J, Ravarino A, Ledda F, Fanni D Molecules. 2021; 26(21).

PMID: 34771023 PMC: 8587580. DOI: 10.3390/molecules26216614.


Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol.

Perera M, El Khoury J, Chinni V, Bolton D, Qu L, Johnson P BMJ Open. 2020; 10(12):e040580.

PMID: 33268419 PMC: 7712927. DOI: 10.1136/bmjopen-2020-040580.

References
1.
Massip-Salcedo M, Zaouali M, Padrissa-Altes S, Casillas-Ramirez A, Rodes J, Rosello-Catafau J . Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion. Hepatology. 2007; 47(2):461-72. DOI: 10.1002/hep.21935. View

2.
BERGMEYER H, Horder M, Rej R . International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate.... J Clin Chem Clin Biochem. 1986; 24(7):497-510. View

3.
Wetherell D, Baldwin G, Shulkes A, Bolton D, Ischia J, Patel O . Zinc ion dyshomeostasis increases resistance of prostate cancer cells to oxidative stress via upregulation of HIF1α. Oncotarget. 2018; 9(9):8463-8477. PMC: 5823553. DOI: 10.18632/oncotarget.23893. View

4.
Chaudry I, Clemens M, Ohkawa M, Schleck S, Baue A . Restoration of hepatocellular function and blood flow following hepatic ischemia with ATP-MgCl2. Adv Shock Res. 1982; 8:177-86. View

5.
Olthof P, van Golen R, Meijer B, van Beek A, Bennink R, Verheij J . Warm ischemia time-dependent variation in liver damage, inflammation, and function in hepatic ischemia/reperfusion injury. Biochim Biophys Acta Mol Basis Dis. 2016; 1863(2):375-385. DOI: 10.1016/j.bbadis.2016.10.022. View